Strategy for probably the most lethal type of Cancer of the breast!
 | Ganoderma mushroom Inflammatory cancer of the breast, also called IBC has been determined to function as the most lethal, yet sadly least understood of all of the types of cancer of the breast cells. What is known is that the lethality arises from its inherent lack of tumor mass which makes it incredibly difficult to detect and its particular means of attacking the the lymphatic system. Reishi mushroom Inflammatory Breast cancers differs from other stage 4 cervical cancer varieties in the manner it forms what is called “tumor spheroids”. Those forms of tumors have been located to become far more adhesive to cells. Ganoderma mushroom There's been much research done lately with this kind of cancer due to its extreme lethality. While surgery, drugs, radiation, chemotherapy and other such intrusive treatments happen to be popular there is a growing camp of forward thinking doctors that have seen amazing promise with all the new “shining star” for oncologists. Ganoderma (commercially sold as Karmic Balance ReishiCor) can be a medicinal mushroom this is the leading ingredient in Karmic Balance ReishiCor. Reishi contains biological compounds which can be cytotoxic against cancer cells. Yes, you read that right- TOXIC for the largest kind of Cancer of the breast cells! Multiple results reveal that Reishi selectively inhibits cancer cell viability although it does not affect the viability of noncancerous cells as shown in tests on mammals. Which means it attacks the cell you want gone, and instead gives off the healthy ones alone! Reishi gives Inflammatory Breast Cancer a “1-2” punch by working to break the tumor spheroids bond as well. This point alone gives Reishi incredible promise to be used by those genetically predisposed to breast cancers. Take the fight to breast cancer-be proactive! http://www.karmicbalancehealth.com/reishicor-with-immune-assisttm.html Nutr Cancer. 2011 Oct;63(7):1085-94. Epub 2011 Sep 2. Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer. Martínez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF. Source Department of Biochemistry, Universidad Central del Caribe, Med school, Bayamón, Puerto Rico. mmmtz92@gmail.com |
